Nicolas Encina
About Nicolas Encina
Nicolas Encina is the Executive Director and Co-Founder of the International Consortium on Newborn Sequencing (ICoNS) and serves in strategic roles at Ariadne Labs and Harvard T.H. Chan School of Public Health. He has a diverse educational background and extensive experience in healthcare innovation and strategic planning.
Company
Nicolas Encina is currently associated with multiple organizations. He works as the Executive Director and Co-Founder at the International Consortium on Newborn Sequencing (ICoNS), as the Director of Strategic Planning and Co-Founder in Precision Population Health at Ariadne Labs, and as the Director of Strategic Planning in Precision Population Health at Harvard T.H. Chan School of Public Health. Additionally, he is a Co-Founder at Modelo Health Inc.
Title
Nicolas Encina holds multiple leadership roles across different organizations. He serves as the Executive Director and Co-Founder of ICoNS, Director of Strategic Planning and Co-Founder at Ariadne Labs, and Director of Strategic Planning at Harvard T.H. Chan School of Public Health. He is also a Co-Founder at Modelo Health Inc.
Education and Expertise
Nicolas Encina has an extensive educational background. He earned an M.B.A. in Healthcare from Yale School of Management, an M.S. in Computer Science from Washington University in St. Louis, and an M.S. in Cell Biology from the University of Dayton. He also holds a B.S. in Biology and Psychology from the University of Rochester. His expertise includes public speaking, strategic oversight, and involvement in the Human Genome Project's BLAST lab.
Background
Nicolas Encina has held various key positions in both academia and industry. He was an Advisor and EIR at Bain Capital Ventures, a member of the Scientific Advisory Board at Cogen Therapeutics, and held the role of Chief Science & Technology Officer at Ariadne Labs and Harvard T.H. Chan School of Public Health. His industry experience includes serving as VP & Managing Director at PerkinElmer's Innovation Lab and as CEO and Co-Founder of Wingu Inc.
Achievements
Nicolas Encina has played an influential role in forming and growing a global consortium on newborn sequencing. He has been crucial in the creation and management of flagship AI/data product lines for publicly traded companies. His strategic contributions include graduate work in the Human Genome Project’s BLAST lab at Washington University Medical School. He has demonstrated strong leadership and strategic planning skills across various innovative healthcare projects.